Acarix at DGK Herztage Berlin 10-12 Okt 2019

Meet the expert Dr Klaus Remde

10 Oktober 10:00 -12:00 & 14:00 -16.30 Uhr 

11 Oktober 14:00 -16:30 Uhr 

Sie finden uns im Maritim Hotel Berlin

Stand Nr 19, im Foyer, Saal Maritim 





About Acarix
Acarix is a Swedish medical device company that innovates solutions for rapid AI-based rule out of Coronary Artery Disease (CAD). The CE approved and FDA DeNovo cleared Acarix CADScor®System is intended for patients experiencing chest pain with suspected CAD and designed to help reduce millions of unnecessary, invasive and costly diagnostic procedures. The CADScor system calculates a patient-specific CAD-score non-invasively in less than10 minutes and can help rule out more than one third of patients with at least 96% certainty of not being sick (in a population with approx. 10% CAD prevalence). Acarix is listed on the Nasdaq First North Premier Growth Market (ticker: ACARIX). Redeye AB (+46 (0)8 121 576 90, is Certified Advisor of Acarix.

For more information, please visit